Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

VLP Therapeutics to Initiate First Clinical Trial of VLPM01 Malaria Vaccine

americanpharmaceuticalreviewFebruary 19, 2019

Tag: VLP Therapeutics , VLPM01 , malaria vaccine , CHMI

PharmaSources Customer Service